Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 216

    1.

    Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

    Jonas JB, Akkoyun I, Kreissig I, Degenring RF.

    Br J Ophthalmol. 2005 Mar;89(3):321-6.PMID: 15722313 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

    Jonas JB, Kreissig I, Degenring RF.

    Br J Ophthalmol. 2004 Dec;88(12):1557-62.PMID: 15548812 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

    Jonas JB, Kreissig I, Budde WM, Degenring RF.

    Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

    Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

    5.

    Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.

    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.

    Ophthalmology. 2006 May;113(5):800-4. Epub 2006 Mar 13.PMID: 16530840 [PubMed - indexed for MEDLINE]Related articles

    6.
    7.

    Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.

    Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Jonas JB.

    Br J Ophthalmol. 2005 Aug;89(8):999-1003.PMID: 16024853 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

    Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I.

    Eye (Lond). 2005 Feb;19(2):163-70.PMID: 15218517 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Harder B, Kamppeter BA.

    Am J Ophthalmol. 2004 Dec;138(6):970-7.PMID: 15629288 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema]

    Jonas JB, Degenring R.

    Klin Monbl Augenheilkd. 2002 Jun;219(6):429-32. German. PMID: 12136438 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

    Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF.

    Arch Ophthalmol. 2004 Feb;122(2):218-22.PMID: 14769599 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal cortisone injection for refractory diffuse diabetic macular edema.

    Er H, Yilmaz H.

    Ophthalmologica. 2005 Nov-Dec;219(6):394-400.PMID: 16286802 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.

    Avitabile T, Longo A, Reibaldi A.

    Am J Ophthalmol. 2005 Oct;140(4):695-702.PMID: 16226521 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration.

    Jonas JB, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Libondi T, Spandau UH, Vossmerbaeumer U.

    Ophthalmic Res. 2009;41(1):21-7. Epub 2008 Oct 13.PMID: 18849638 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.

    Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF.

    Eur J Ophthalmol. 2005 Nov-Dec;15(6):751-8.PMID: 16329061 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

    Avci R, Kaderli B.

    Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):28-35. Epub 2005 Jul 21.PMID: 16034605 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intraocular pressure after intravitreal injection of triamcinolone acetonide.

    Jonas JB, Kreissig I, Degenring R.

    Br J Ophthalmol. 2003 Jan;87(1):24-7.PMID: 12488256 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

    Batioğlu F, Ozmert E, Parmak N, Celik S.

    Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.PMID: 17453151 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study.

    Jonas JB, Kamppeter BA, Harder B, Vossmerbaeumer U, Sauder G, Spandau UH.

    J Ocul Pharmacol Ther. 2006 Jun;22(3):200-7.PMID: 16808682 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data